184 related articles for article (PubMed ID: 15389000)
1. High-frequency of quinolone-resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes.
Uthman A; Heller-Vitouch C; Stary A; Bilina A; Kuchinka-Koch A; Söltz-Szöts J; Tschachler E
Sex Transm Dis; 2004 Oct; 31(10):616-8. PubMed ID: 15389000
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae].
Xie P; Mi ZH; Li Q; Zhang J; Xiao CY
Zhonghua Nan Ke Xue; 2003; 9(4):275-8. PubMed ID: 12931370
[TBL] [Abstract][Full Text] [Related]
4. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India.
Chaudhry U; Ray K; Bala M; Saluja D
Sex Transm Infect; 2002 Dec; 78(6):440-4. PubMed ID: 12473806
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan.
Shigemura K; Shirakawa T; Okada H; Hinata N; Acharya B; Kinoshita S; Kofuku T; Kawabata M; Kamidono S; Arakawa S; Gotoh A
Sex Transm Dis; 2004 Mar; 31(3):180-4. PubMed ID: 15076932
[TBL] [Abstract][Full Text] [Related]
6. Quinolone resistance-determining region mutations and por type of Neisseria gonorrhoeae isolates: resistance surveillance and typing by molecular methodologies.
Giles JA; Falconio J; Yuenger JD; Zenilman JM; Dan M; Bash MC
J Infect Dis; 2004 Jun; 189(11):2085-93. PubMed ID: 15143477
[TBL] [Abstract][Full Text] [Related]
7. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.
Lindbäck E; Rahman M; Jalal S; Wretlind B
APMIS; 2002 Sep; 110(9):651-7. PubMed ID: 12529019
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
9. Exploring quinolone resistance-determining region in
Sood S; Agarwal M; Bala M; Mahajan N; Singh R; Kapil A; Sreenivas V; Ram RJ; Kar HK; Sharma VK;
Indian J Med Res; 2017 Jul; 146(Supplement):S64-S69. PubMed ID: 29205198
[TBL] [Abstract][Full Text] [Related]
10. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
[TBL] [Abstract][Full Text] [Related]
11. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.
Uehara AA; Amorin EL; Ferreira Mde F; Andrade CF; Clementino MB; de Filippis I; Neves FP; Pinto Tde C; Teixeira LM; Giambiagi-Demarval M; Fracalanzza SE
J Clin Microbiol; 2011 Dec; 49(12):4208-12. PubMed ID: 21976763
[TBL] [Abstract][Full Text] [Related]
13. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae.
Dewi BE; Akira S; Hayashi H; Ba-Thein W
Sex Transm Dis; 2004 Jun; 31(6):353-9. PubMed ID: 15167645
[TBL] [Abstract][Full Text] [Related]
14. Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
Zhou W; Du W; Cao H; Zhao J; Yang S; Li W; Shen Y; Zhang S; Du W; Zhang X
J Clin Microbiol; 2004 Dec; 42(12):5819-24. PubMed ID: 15583317
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
Ng LK; Sawatzky P; Martin IE; Booth S
Sex Transm Dis; 2002 Dec; 29(12):780-8. PubMed ID: 12466720
[TBL] [Abstract][Full Text] [Related]
16. Analysis of quinolone resistance mechanisms in a sparfloxacin-resistant clinical isolate of Neisseria gonorrhoeae.
Tanaka M; Nakayama H; Haraoka M; Nagafuji T; Saika T; Kobayashi I
Sex Transm Dis; 1998 Oct; 25(9):489-93. PubMed ID: 9800262
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene.
Ruiz J; Marco F; Sierra JM; Aguilar L; Garcia-Mendez E; Mensa J; Jiménez De Anta MT; Vila J
Int J Antimicrob Agents; 2003 Jul; 22(1):73-6. PubMed ID: 12842332
[TBL] [Abstract][Full Text] [Related]
19. Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Shultz TR; Tapsall JW; White PA
Antimicrob Agents Chemother; 2001 Mar; 45(3):734-8. PubMed ID: 11181352
[TBL] [Abstract][Full Text] [Related]
20. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
